Tagged Articles

non-Hodgkins lymphoma 10 articles

Alleged Monsanto Roundup Cancer Victim Shares Plight With CNN

After years of spraying Monsanto’s Roundup herbicide on her coffee farm in Hawaii, Christine Sheppard developed non-Hodgkin’s lymphoma. Now, as a stage IV cancer patient, she is one of more than 800 other cancer patients who are pursuing legal action against the agrochemical giant, alleging Roundup caused their cancer. Ms. Sheppard, 67, told CNN that she learned of her cancer after her right leg “swelled up enormously.” An ultrasound found that her body was full of late-stage, large-cell cancer. She is undergoing chemotherapy, which has diminished her mobility and quality of life. Beyond her constant pain, she is experiencing “a ... Read More

BP, Chevron and 18 others named in benzene lawsuit

In a recent benzene lawsuit, 20 companies were named as defendants, including BP, Chevron, Texaco, Atlantic Richfield, BASF, Citgo, ConocoPhillips, ExxonMobil, Shell, Sunoco, Total, Union Oil and Valero. Plaintiffs Daniel and Renee Sikes have filed a lawsuit against the companies at the end of December over long-term exposure to benzene that allegedly caused a life-threatening disease. Daniel Sikes worked at the Sunoco facility in Nederland from 1976-2013, after which Sikes developed Non-Hodgkins lymphoma. According to the suit, the companies negligently exposed him to benzene, a key ingredient in gasoline, without warning him of the dangers. Non-Hodgkins lymphoma is an incurable disease that affects ... Read More

Fumes from Hookah Water Pipes Found to Contain Benzene

Hookahs, a type of water pipe, are considered to be a safe a popular way to smoke, and a healthier alternative to cigarette smoking. But a new study finds that the fumes from hookahs’ water pipes contain the toxic chemical benzene. Nada Kassem, the study author and associate director of the Center for Behavioral Epidemiology and Community Health at San Diego State University, said, “In contrast to what is believed, hookah tobacco smoking is not a safe alternative to smoking other forms of tobacco.” She further explained, “Hookah tobacco smoking involves the use of burning charcoal that is needed to heat the hookah tobacco to ... Read More

Benzene: A sweet-smelling killer

Benzene, a key ingredient in gasoline, is a sweet-smelling chemical that is used to make plastics, lubricants, dyes and adhesives. It has also been suspected as a link to several blood disorders and cancers, specifically leukemia. As the 17th-most produced chemical in the U.S., benzene can be found in cigarettes and car exhaust fumes. Before federal regulators set occupational exposure limits in 1987, benzene was a common solvent used in pure form by offshore workers and petrochemical industry workers. Other workers who may be at risk are auto mechanics, gas station attendants and even printers because of the extended periods of ... Read More

Fresenius faces lawsuits for patent infringement

Fresenius Kabi, one of four business segments of the worldwide dialysis giant Fresenius Medical Care, was slapped with a lawsuit this week alleging that the company was violating patents for the cancer dug Isodax. Drug makers Celgene Corp. and Astellas Pharma claim that Fresenius Kabi filed an abbreviated new drug application with the Food and Drug Administration (FDA) to manufacture and sell a generic version of romidepsin for injection. The companies allege that doing so violates two active patents. Isodax is used to treat cutaneous T-cell lymphoma, a type of non-Hodgkin’s lymphoma, in patients who have received at least one ... Read More

Hepatitis B reactivation warnings added to drugs Arzerra, Rituxan

The Food and Drug Administration (FDA) announced new black box warnings for potentially fatal reactivation of hepatitis B viruses (HBV) were added to two drugs – one an immune suppressant and the other an anti-cancer medication. The warnings will be added to the labels of Arzerra (ofatumumab) and Rituxan (rituximab). Arzerra is used to treat chronic lymphocytic leukemia (CLL) in patients who have further disease after treatment with the anti-cancer drugs fludarabine and alemtuzumab. Rituxan is used to treat non-Hodgkin’s lymphoma and CLL. It is also used to treat other medical conditions, including rheumatoid arthritis, granulomatosis with polyanglitis, and microscopic ... Read More

Bristol-Myers Squibb recalls chemotherapy drug

More than 31,000 units of a chemotherapy drug are being recalled by manufacturer Bristol-Myers Squibb Co., because one vial was found to be overfilled, which puts patients at risk for overdose. The recall affects 10 lots of BiCNU, an injection of the drug carmustine, which is used to treat brain tumors, multiple myeloma, Hodgkin’s disease and non-Hodgkin’s lymphoma. An overdose of BiCNU could result in lung or kidney toxicity. No adverse events have yet been reported. BiCNU was manufactured by Ben Venue Laboratories, a manufacturing contractor that Bristol-Myers Squibb no longer uses. The recall affects products sold in the United ... Read More

New study can leave women even more confused about HRT

New research on hormone replacement therapy (HRT) and birth control pills could leave women even more confused about the risks and benefits of the drugs, doctors warn. The research, published in the Journal of NeuroInterventional Surgery, suggests that pills containing estrogen may help lower the risk for brain aneurysms. The news follows a tidal wave of studies that linked HRT to breast cancer and other deadly conditions including ovarian cancer, non-Hodgkin’s lymphoma, heart attack, stroke and blood clots. “I think women are confused,” Dr. Joanna Longstaffe, clinical director of Independent General Practice told Wales Online. “I have far fewer people ... Read More

Rheumatoid Arthritis drug linked to serious neurological disorder

The Food and Drug Administration (FDA) has received a third case of a serious and often fatal neurological disorder known as progressive multifocal leukoencephalopathy (PML) in a patient with rheumatoid arthritis (RA) treated with the drug Rituxan (rituximab). The report has led the agency to inform rheumatological health care professionals that patients with RA who have received Rituxan are at an increased risk of PML. Physicians should consider the risks in any patient treated with Rituxan who presents new onset neurological manifestations. The FDA advises consultation with a neurologist, brain MRI, and lumbar puncture should be considered as clinically indicated. ... Read More